Angiomatous lymphoid hamartoma

Inhibitory effects on erythropoiesis, growth, and primary hemostasis

George R. Buchanan, John J. Chipman, Brian L. Hamilton, William H. Daughaday

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

An 11-year-old boy was noted to have microcytic anemia, growth retardation, polyclonal hypergammaglobulinemia, and abnormal platelet function. An angiomatous lymphoid hamartoma was removed from the retroperitoneal space. Postoperatively the child exhibited a dramatic growth spurt and complete resolution of the abnormal laboratory measurements. Studies were performed before and after tumor removal to investigate the nature of the associated anemia, growth retardation, and altered hemostasis. There was no evidence of iron deficiency, thalassemia, or an antierythropoietin factor. Prolonged bleeding time and impaired ristocetin-induced platelet aggregation normalized following tumor resection. Serum obtained before surgery inhibited lymphocyte proliferation in mixed lymphocyte culture as well as fibroblast growth in vitro. Detailed study of growth regulatory hormones failed to reveal significant alterations except for significantly reduced somatomedin which normalized after surgery. The factor(s) which inhibit in vitro cellular growth and lower in vivo plasma somatomedin concentration remain unknown.

Original languageEnglish (US)
Pages (from-to)382-388
Number of pages7
JournalThe Journal of Pediatrics
Volume99
Issue number3
DOIs
StatePublished - 1981

Fingerprint

Hamartoma
Erythropoiesis
Hemostasis
Growth
Somatomedins
Anemia
Lymphocytes
Retroperitoneal Space
Ristocetin
Hypergammaglobulinemia
Bleeding Time
Thalassemia
Platelet Aggregation
Growth Hormone
Neoplasms
Blood Platelets
Iron
Fibroblasts
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Angiomatous lymphoid hamartoma : Inhibitory effects on erythropoiesis, growth, and primary hemostasis. / Buchanan, George R.; Chipman, John J.; Hamilton, Brian L.; Daughaday, William H.

In: The Journal of Pediatrics, Vol. 99, No. 3, 1981, p. 382-388.

Research output: Contribution to journalArticle

Buchanan, George R. ; Chipman, John J. ; Hamilton, Brian L. ; Daughaday, William H. / Angiomatous lymphoid hamartoma : Inhibitory effects on erythropoiesis, growth, and primary hemostasis. In: The Journal of Pediatrics. 1981 ; Vol. 99, No. 3. pp. 382-388.
@article{978b835758ad4c2e80114e8e3a91832e,
title = "Angiomatous lymphoid hamartoma: Inhibitory effects on erythropoiesis, growth, and primary hemostasis",
abstract = "An 11-year-old boy was noted to have microcytic anemia, growth retardation, polyclonal hypergammaglobulinemia, and abnormal platelet function. An angiomatous lymphoid hamartoma was removed from the retroperitoneal space. Postoperatively the child exhibited a dramatic growth spurt and complete resolution of the abnormal laboratory measurements. Studies were performed before and after tumor removal to investigate the nature of the associated anemia, growth retardation, and altered hemostasis. There was no evidence of iron deficiency, thalassemia, or an antierythropoietin factor. Prolonged bleeding time and impaired ristocetin-induced platelet aggregation normalized following tumor resection. Serum obtained before surgery inhibited lymphocyte proliferation in mixed lymphocyte culture as well as fibroblast growth in vitro. Detailed study of growth regulatory hormones failed to reveal significant alterations except for significantly reduced somatomedin which normalized after surgery. The factor(s) which inhibit in vitro cellular growth and lower in vivo plasma somatomedin concentration remain unknown.",
author = "Buchanan, {George R.} and Chipman, {John J.} and Hamilton, {Brian L.} and Daughaday, {William H.}",
year = "1981",
doi = "10.1016/S0022-3476(81)80322-8",
language = "English (US)",
volume = "99",
pages = "382--388",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Angiomatous lymphoid hamartoma

T2 - Inhibitory effects on erythropoiesis, growth, and primary hemostasis

AU - Buchanan, George R.

AU - Chipman, John J.

AU - Hamilton, Brian L.

AU - Daughaday, William H.

PY - 1981

Y1 - 1981

N2 - An 11-year-old boy was noted to have microcytic anemia, growth retardation, polyclonal hypergammaglobulinemia, and abnormal platelet function. An angiomatous lymphoid hamartoma was removed from the retroperitoneal space. Postoperatively the child exhibited a dramatic growth spurt and complete resolution of the abnormal laboratory measurements. Studies were performed before and after tumor removal to investigate the nature of the associated anemia, growth retardation, and altered hemostasis. There was no evidence of iron deficiency, thalassemia, or an antierythropoietin factor. Prolonged bleeding time and impaired ristocetin-induced platelet aggregation normalized following tumor resection. Serum obtained before surgery inhibited lymphocyte proliferation in mixed lymphocyte culture as well as fibroblast growth in vitro. Detailed study of growth regulatory hormones failed to reveal significant alterations except for significantly reduced somatomedin which normalized after surgery. The factor(s) which inhibit in vitro cellular growth and lower in vivo plasma somatomedin concentration remain unknown.

AB - An 11-year-old boy was noted to have microcytic anemia, growth retardation, polyclonal hypergammaglobulinemia, and abnormal platelet function. An angiomatous lymphoid hamartoma was removed from the retroperitoneal space. Postoperatively the child exhibited a dramatic growth spurt and complete resolution of the abnormal laboratory measurements. Studies were performed before and after tumor removal to investigate the nature of the associated anemia, growth retardation, and altered hemostasis. There was no evidence of iron deficiency, thalassemia, or an antierythropoietin factor. Prolonged bleeding time and impaired ristocetin-induced platelet aggregation normalized following tumor resection. Serum obtained before surgery inhibited lymphocyte proliferation in mixed lymphocyte culture as well as fibroblast growth in vitro. Detailed study of growth regulatory hormones failed to reveal significant alterations except for significantly reduced somatomedin which normalized after surgery. The factor(s) which inhibit in vitro cellular growth and lower in vivo plasma somatomedin concentration remain unknown.

UR - http://www.scopus.com/inward/record.url?scp=0019481435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019481435&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(81)80322-8

DO - 10.1016/S0022-3476(81)80322-8

M3 - Article

VL - 99

SP - 382

EP - 388

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -